Show Me The Money: Salaries, Red Tape Challenge FDA Recruiting
This article was originally published in The Rose Sheet
Executive Summary
FDA’s drug center continues to operate with a staffing shortage at a time of tremendous pressure to implement new authorities, with Director Janet Woodcock scrambling to find senior managers to lead top initiatives. Direct hiring authority has helped but doesn’t fully address FDA’s recruiting challenges: too much red tape and too little money.
You may also be interested in...
Califf Lowering FDA Drawbridge To Work With External Expertise
In an exclusive interview, new commissioner Robert Califf says FDA will tap knowledge beyond its walls, without compromising agency independence.
FDA Talent Hunt: Better To Recruit From Academia Than Industry?
CDER Oncology office head Richard Pazdur says making FDA more academic could help with retention. In addition to having fewer staff than needed to complete its work, FDA’s hiring problem makes it difficult for the agency to stay abreast of new scientific discoveries and technology.
Hamburg Departure Hinged On Filling FDA Leadership Roster
Susan Mayne brings “new strength and focus to CFSAN” and medical countermeasures expert Luciana Borio moves to chief scientist role. Hamburg offers previews on leadership approaches of Stephen Ostroff and Robert Califf.